Smith+Nephew adds total hip arthroplasty to Cori surgical robot

Smith+Nephew (NYSE:SNN) today announced that it has expanded the indications on its Cori Surgical System to include total hip arthroplasty.

The London-based company previously designed the handheld robotic solution for total knee arthroplasty. The new indication with RI.Hip Navigation is designed to help maximize accuracy and reproducibility by delivering patient-specific component alignment to THA, according to the company.

“The addition of RI.Hip Navigation on the Cori System further strengthens Smith+Nephew’s Real Intelligence digital ecosystem and underscores our commitment to advancing clinical outcomes in total hip arthroplasty,” Randy Kilburn, EVP and general manager of reconstruction, robotics and digital surgery, said in a news release. “We look forward to offering the possibility of further improving patient outcomes and satisfaction to a broader surgeon community with the rapidly expanding adoption of our Cori Surgical System.…

Read more
  • 0

Medtronic’s Kowal explains how remote medtech got its groove back

In this week’s DeviceTalks Weekly Podcast, Dr. Robert Kowal CMO of Medtronic’s cardiac rhythm and heart failure business and vice president of medical affairs, explains how new tech, savvy patients, eager physicians and, yes, COVID-19, has fueled a renaissance for remote technology, once seen as a mature, staid business.

Kowal, who left clinical practice to join Medtronic in 2017, identifies the building blocks that have allowed companies like Medtronic to provide devices that provided essential connectivity during the ongoing pandemic.

“Five or 10 years ago we were all saying cardiac implantable devices were a mature market, not much happening,” Kowal says. “Now, between the technology, these new devices and digital interconnectivity I don’t see it as mature any more. It’s a spry, young area once again. It’s. a lot of fun to be working in it right now.”

Kowal shares stories on how connectivity migh…

Read more
  • 0

Smith + Nephew launches Novostitch Pro meniscal repair system

Smith + Nephew (NYSE:SNN) announced today that it launched the Novostitch Pro meniscal repair system after winning CE Mark approval.

London-based Smith + Nephew is launching the Novostitch Pro in Europe to expand meniscal repair options where the only previous option was removal, according to a news release. The system repairs meniscal tears and closes the gap on meniscectomy.

Novostitch Pro allows surgeons to place stitches arthroscopically in tight joint compartments, using a meniscus-to-meniscus circumferential compression stitch to repair tears that may not have been repaired in the past, the company said.

Smith + Nephew has now made the Novostitch Pro meniscal repair system commercially available in the U.S., Europe, the Middle East, Africa and other select countries.

“We are delighted to be able to offer this ground-breaking technology to surgeons in Europe,” Smith + Nephew VP of marketing for sports medicine EMEA Terry Byca sa…

Read more
  • 0

Smith & Nephew is using vibrating bracelets to encourage social distancing

Smith & Nephew (NYSE:SNN) is utilizing devices made by Tharsus to help with social distancing as the company returns to the office.

A report in The Telegraph outlines how the London-based medtech company is being providing vibrating bracelets from Blythe, England-based Tharsus to keep the six-foot (two-meter) distance widely recommended for preventing the spread of COVID-19.

Get the full story at our sister site, Medical Design & Outsourcing.

Read more
  • 0

Smith+Nephew Launches Aria care management platform

Smith & Nephew (NYSE:SNN) announced today that it launched its ARIA digital platform for connecting patient care delivery with providers.

Aria is designed to help clinicians shorten a patient’s post-acute recovery time, develop efficiencies that reduce costs and generate key patient-reported outcome measures, according to a news release.

London-based Smith & Nephew’s platform is powered by the company’s “Real Intelligence” digital ecosystem and “Positive Connections” ASC solutions program. It includes dashboard displays that offer visibility for the patient and provider in an effort to reduce variability in clinical outcomes.

A white paper evaluation of the MiJourney platform used for ARIA found that it created a 45% reduction in readmission rates for some customers and an approximate 35% reduction in 90-day episodic costs, along with a reduced length of stay in nursing facilities by up to 30% for patient…

Read more
  • 0

DTW Podcast: 10 ways medtech is finding its footing amid COVID-19

When COVID-19 set upon the U.S. in March, medtech executives had a month at most to tell Wall Street analysts how the pandemic had hit the industry’s largest companies. We heard about short-term hits in revenues, procedures and employee headcounts, but uncertainty clearly ruled the day.

Over the past few weeks, medtech executives from several leading companies reported back to analysts with a full quarter under their belt. To be sure, no one can claim to hold a full grasp on this crisis, but a survey of the calls reveals steps and adjustments that companies are taking to thrive beyond the pandemic.

In this podcast, we’ll list our Top 10.

Don’t miss an episode! Subscribe to DeviceTalks Weekly on your podcast players. It’s available on Apple Podcasts, Spotify and other podcast channels.

DeviceTalks by MassDevice · Ten ways medtech companies are finding their footing during the pandemic


Read more
  • 0

MedTech 100 roundup: Industry hits another mid-pandemic high

Despite a minor regression week-over-week, the medtech industry’s stocks hit another milestone as the COVID-19 rebound remains in progress.

MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — sat at 89.01 points at the end of last week (July 31). Overall, medtech stocks saw a -0.3% increase from the 89.29-point total at the same time a week prior (July 24).

On July 30, the index reached 90.37 points, marking its highest point since that pre-pandemic high, with the previous mid-pandemic high (90.11) coming last week.

The most recent high mark represents just a -2.1% dip from the Feb. 19 high point of 92.32, marking the smallest margin of decline over the past five months.

Meanwhile, the S&P 500 Index saw a 1.7% increase from July 24 to July 31, and the Dow Jones Index posted a -0.2% drop over the same period of time.

Medtech’s lowest point during the COVID-19 pandemic remains at …

Read more
  • 0

Smith+Nephew launches total hip arthroplasty system

Smith+Nephew (NYSE:SNN) today said it launched its RI Hip Navigation system for total hip arthroplasty.

The technology is designed to maximize accuracy and reproducibility to deliver patient-specific component alignment for surgeons when assessing individual total hip arthroplasty cases.

RI Hip Navigation helps surgeons take control of a patient’s pelvic tilt, leg length and offset measurement. It also helps with cup placement to give a predicted view of the post-op AP X-ray in surgery.

Smith+Nephew said the system is also designed to help hospitals and ambulatory surgery centers by using express workflows and image free technology since the technology does not require a CT scan.

The company acquired Brainlab’s orthopedic joint reconstruction business in May 2019 and RI Hip Navigation is an early deliverable from that acquisition, according to the company.

“The integration of the Orthopaedic Joint Reconstruction Business h…

Read more
  • 0

Smith+Nephew launches next-gen surgical robotics system

The Cori surgical system [Image courtesy of Smith+Nephew]

Competition continues to heat up in the robotic orthopedic surgery space, with Smith+Nephew (LON:SN) today announcing the launch of its next-gen Cori surgical system.

Cleared by FDA and available for both total and unicompartmental knee arthroplasty, the handheld Cori robotics platform is meant to be faster than S+N’s previous Navio system. On top of Cori, the British medtech giant is also launching its Real Intelligence suite of digital surgery solutions that are meant to improve patient engagement, pre-operative planning, digital and robotic surgery, post-operative assessment and outcomes measurement.

“The Real Intelligence brand is a statement of how Smith+Nephew thinks, innovates,and reimagines surgery,” said Skip Kiil, president of Orthopaedics for Smith+Nephew.

“The introduction of the Cori surgical system’…

Read more
  • 0

MedTech 100 roundup: Stocks tick back up to open July

After a solid start to July, the medtech industry continues to experience a stock market roller coaster amid the COVID-19 pandemic.

MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — sat at 84.25 points at the end of last week (July 3). That total represents a 2.9% increase from the 81.88-point total at the same time a week prior (June 26), resulting in another significant direction change, following a -3.7% dip just one week before.

Meanwhile, the S&P 500 Index saw a 4% bump from June 26 to July 2 (market close before a holiday), and the Dow Jones Index fared similarly well, posting a 3.2% increase over the same period of time. Both indexes mirrored the medtech industry’s changes, having each posted decreases the week prior.

Medtech’s lowest point during the COVID-19 pandemic remains at 62.13 on March 23. Since then, the industry’s stocks have experienced 35.6% growth in total. Stocks in the indu…

Read more
  • 0

Smith & Nephew expects 29% sales dip in Q2

Smith & Nephew (NYSE:SNN) said today it expects second-quarter revenues to dip by 29% due to the coronavirus pandemic, although results gradually improved as time went on.

Sales were hardest hit in the company’s orthopedic reconstruction, sports medicine and ENT businesses due to the pandemic-related lockdown and pause in elective surgeries. The company’s advanced wound management and trauma businesses fared better, executives said in a statement, but “significant uncertainty and geographical variation” persist, they added.

While the revenue drop is in line with SNN’s previously published outlook, sales gradually improved over the quarter, with revenue declines of -47% in April, -27% in May and -12% in June, they noted.

“As a result of the trading performance across the first and second quarters, we continue to expect that the first half trading margin will be substantially down on the prior year,” company of…

Read more
  • 0

Smith & Nephew Regeneten bioinductive implant wins CE mark

Smith & Nephew (NYSE:SNN) announced today that its Regeneten bioinductive implant for rotator cuff procedures received CE Mark approval in Europe.

Regeneten, a collagen-based implant, supports the body’s natural healing process by inducing the growth of new tendon-like tissue to biologically augment the existing tendon and disrupt disease progression.

The implant, which is the size of a postage stamp, is delivered arthroscopically through a small incision over the location of the rotator cuff tendon injury and completely resorbed within six months. More than 40,000 procedures with Regeneten have been completed since it was introduced in the U.S., according to a news release.

London-based Smith & Nephew’s implant can be used in procedures ranging from partial-thickness tears to large (3-5 cm) and massive (5 cm and more) thickness tears.

“We are delighted to gain CE Mark for Regeneten and be able to offer up this ground-br…

Read more
  • 0